Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

Saved in:
Bibliographic Details
Published inDiabetologia Vol. 48; no. 4; pp. 612 - 615
Main Authors Holst, J. J., Deacon, C. F.
Format Journal Article
LanguageEnglish
Published Germany Springer Nature B.V 01.04.2005
Subjects
Adenosine Deaminase - metabolism
Adenosine Deaminase Inhibitors
Blood Glucose - metabolism
Diabetes Mellitus, Type 2 - drug therapy
Dipeptidyl Peptidase 4 - metabolism
Enzyme Inhibitors - adverse effects
Enzyme Inhibitors - pharmacology
Enzyme Inhibitors - therapeutic use
Gastric Emptying - drug effects
Glucagon - metabolism
Glucagon - physiology
Glucagon-Like Peptide 1
Glycoproteins - antagonists & inhibitors
Glycoproteins - metabolism
Homeostasis - drug effects
Humans
Models, Biological
Nausea - chemically induced
Peptide Fragments - metabolism
Peptide Fragments - physiology
Protein Precursors - metabolism
Protein Precursors - physiology
Vomiting - chemically induced
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Scholarly Journals-1
ObjectType-Commentary-1
content type line 14
ObjectType-Article-2
ObjectType-Feature-3
content type line 23
ISSN:0012-186X
1432-0428
DOI:10.1007/s00125-005-1705-7